Cellectis Appoints Bing Wang, PhD, MBA as Chief Financial Officer
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to… Read More »Cellectis Appoints Bing Wang, PhD, MBA as Chief Financial Officer